Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

Rong-Rong Chen · SciRah

Researcher profile · Semantic Scholar

Rong-Rong Chen

Share profile

Rong-Rong Chen — researcher profile on SciRah

h-index: 19
Works: 137
Citations: 1,309

Most-cited papers

Homologous recombination deficiency (HRD) can predict the therapeutic outcomes of immuno-neoadjuvant therapy in NSCLC patients
Zhen Zhou, Zheng-Ping Ding, Jie Yuan, Sheng-Ping Shen +28 more
2022Journal of Hematology & Oncology66 citations Open access
Semantic Scholar
Molecular landscape of ERBB2 alterations in 3000 advanced NSCLC patients
L. Hong, Sonia A Patel, L. Drusbosky, Yu Xiong +9 more
2024npj Precision Oncology56 citations Open access
Semantic Scholar
Identification of Germline Mismatch Repair Gene Mutations in Lung Cancer Patients With Paired Tumor-Normal Next Generation Sequencing: A Retrospective Study
Si-Bo Sun, Yi-Qian Liu, Ann-Kathrin Eisfeld, F. Zhen +10 more
2019Frontiers in Oncology49 citations Open access
Semantic Scholar
Clonal Architecture of EGFR Mutation Predicts the Efficacy of EGFR-Tyrosine Kinase Inhibitors in Advanced NSCLC: A Prospective Multicenter Study (NCT03059641)
X. Ai, Jiu-Wei Cui, Jie-Xia Zhang, Rong-Rong Chen +14 more
2020Clinical Cancer Research36 citations
Semantic Scholar
Prognostic Value of Postoperative Circulating Tumor DNA in Patients With Early- and Intermediate-Stage Hepatocellular Carcinoma
Ke Ye, Qin-Qiao Fan, M. Yuan, Dong Wang +6 more
2022Frontiers in Oncology31 citations Open access
Semantic Scholar
Comprehensive Genomic Profiling of Rare Tumors: Routes to Targeted Therapies
Shu-Hang Wang, Rong-Rong Chen, Yu Tang, Yue Yu +11 more
2020Frontiers in Oncology25 citations Open access
Semantic Scholar
Landscape and Clonal Dominance of Co-occurring Genomic Alterations in Non–Small-Cell Lung Cancer Harboring MET Exon 14 Skipping
X. Le, L. Hong, C. Hensel, Rong-Rong Chen +16 more
2021JCO Precision Oncology24 citations Open access
Semantic Scholar
Liquid biopsy using ascitic fluid and pleural effusion supernatants for genomic profiling in gastrointestinal and lung cancers
Huita Wu, Haonan Ji, Wenhui Yang, Min Zhang +6 more
2022BMC Cancer23 citations Open access
Semantic Scholar
Postoperative circulating tumor DNA can refine risk stratification in resectable lung cancer: results from a multicenter study
R. Fu, Jun Huang, X. Tian, Chao-Yang Liang +13 more
2023Molecular Oncology22 citations Open access
Semantic Scholar
Genomic profiles and tumor immune microenvironment of primary lung carcinoma and brain oligo-metastasis
Zheng-Bo Song, Ling Yang, Zhi-Peng Zhou, Pansong Li +10 more
2021Cell Death and Disease22 citations Open access
Semantic Scholar
Resolving Resistance to Osimertinib Therapy With Afatinib in an NSCLC Patient With EGFR L718Q Mutation.
Xue Yang, Chuan Huang, Rong-Rong Chen, Jun Zhao
2020Clinical Lung Cancer22 citations
Semantic Scholar
Expert consensus on treatment for stage III non‐small cell lung cancer
Yi-Long Wu, Shun Lu, Qing-Hua Zhou, Li Zhang +72 more
2023Medicine Advances20 citations Open access
Semantic Scholar
Comprehensive Genomic Profiling of Rare Tumors in China: Routes to Immunotherapy
Shu-Hang Wang, Yuan Fang, Ning Jiang, Shujun Xing +5 more
2021Frontiers in Immunology19 citations Open access
Semantic Scholar
Comprehensive characterization of genomic and radiologic features reveals distinct driver patterns of RTK/RAS pathway in ground‐glass opacity pulmonary nodules
Fenglei Yu, Mu-Yun Peng, J. Bai, Xiuli Zhu +21 more
2022International Journal of Cancer18 citations Open access
Semantic Scholar
Identification of the Unique Clinical and Genetic Features of Chinese Lung Cancer Patients With EGFR Germline Mutations in a Large-Scale Retrospective Study
Xin-Qing Lin, Mu-Yun Peng, Quan-Fang Chen, M. Yuan +7 more
2021Frontiers in Oncology18 citations Open access
Semantic Scholar
Co-Occurring Alterations of ERBB2 Exon 20 Insertion in Non-Small Cell Lung Cancer (NSCLC) and the Potential Indicator of Response to Afatinib
Bo Yuan, Jun Zhao, Cheng-Zhi Zhou, Xiu-Mei Wang +21 more
2020Frontiers in Oncology18 citations Open access
Semantic Scholar
Mutational profiling of Chinese patients with thyroid cancer
Yaying Du, Shu Zhang, Gang Zhang, Jiaying Hu +6 more
2023Frontiers in Endocrinology16 citations Open access
Semantic Scholar
Circulating tumor DNA analysis predicts recurrence and avoids unnecessary adjuvant chemotherapy in I–IV colorectal cancer
Wenhua Fan, Zhiyuan Xia, Rong-Rong Chen, Dagui Lin +10 more
2024Therapeutic Advances in Medical Oncology15 citations Open access
Semantic Scholar
KRAS Mutation in Rare Tumors: A Landscape Analysis of 3453 Chinese Patients
Shu-Hang Wang, Qin Li, Pei-Wen J. Ma, Yuan Fang +9 more
2022Frontiers in Molecular Biosciences15 citations Open access
Semantic Scholar
Correlation of KMT2 family mutations with molecular characteristics and prognosis in colorectal cancer
C. Liao, Wei Huang, Ming-Lin Lin, Hui Li +6 more
2022International Journal of Biological Markers15 citations Open access
Semantic Scholar
Characteristics of T-Cell Receptor Repertoire and Correlation With EGFR Mutations in All Stages of Lung Cancer
Hua-Xia Yang, Yadong Wang, Z. Jia, Yan-Yu Wang +13 more
2021Frontiers in Oncology15 citations Open access
Semantic Scholar
Identification of the BRAF V600E mutation in a patient with sclerosing pneumocytoma: A case report.
G. Jiang, Min Zhang, Qin-Quan Tan, Shun-Huan Lin +4 more
2019Lung Cancer15 citations
Semantic Scholar
Case Report: Fatal Multiorgan Failure and Heterochronous Pneumonitis Following Pembrolizumab Treatment in a Patient With Large-Cell Neuroendocrine Carcinoma of Lung
Xiao-Hong Xie, Fei Wang, Yinyin Qin, Xin-Qing Lin +9 more
2021Frontiers in Pharmacology14 citations Open access
Semantic Scholar
Targeted DNA profiling and the prevalence of NTRK aberrations in Chinese patients with head and neck cancer.
Jia-Li Xu, Rong-Sheng Wang, Tongshan Wang, Ting-Ting Wang +5 more
2021Oral Oncology14 citations
Semantic Scholar
Successful Treatment of Patients with Refractory High-Grade Serous Ovarian Cancer with GOPC-ROS1 Fusion Using Crizotinib: A Case Report.
Da-Peng Dong, G. Shen, Yong Da, Ming Zhou +3 more
2020The Oncologist13 citations Open access
Semantic Scholar
Genomic landscape and efficacy of HER2-targeted therapy in patients with HER2-mutant non-small cell lung cancer
Yan-Jie Han, Yuanyuan Xiong, Tao Lu, Rong-Rong Chen +4 more
2023Frontiers in Oncology11 citations Open access
Semantic Scholar
Case Report: Long-Term Response to Pembrolizumab Combined With Endocrine Therapy in Metastatic Breast Cancer Patients With Hormone Receptor Expression
Dingyong Wu, Shuk-Kuen Tang, R. Ye, Dongmei Li +5 more
2021Frontiers in Immunology11 citations Open access
Semantic Scholar
Genetic and treatment profiles of patients with concurrent Epidermal Growth Factor Receptor (EGFR) and Anaplastic Lymphoma Kinase (ALK) mutations
Xiaodan Yang, J. Zhong, Zhuo Yu, Ming-Lei Zhuo +4 more
2021BMC Cancer11 citations Open access
Semantic Scholar
A multicenter real-world study of tumor-derived DNA from pleural effusion supernatant in genomic profiling of advanced lung cancer
Shidai Jin, Cheng-Zhi Zhou, X. Hou, Zai-Wen Fan +6 more
2020Translational Lung Cancer Research11 citations Open access
Semantic Scholar
Temporal Heterogeneity of Resistance Mechanisms to EGFR-TKI Identified in a Patient With Lung Adenocarcinoma and Sarcomatoid Transformation.
Jinyang Zheng, Jin-Feng Zhu, Kelian Zhang, M. Yuan +3 more
2020Clinical Lung Cancer10 citations Open access
Semantic Scholar
Perioperative circulating tumor DNA analysis to predict patient prognosis in liver cancer.
Le-Du Zhou, Ying Xu, Dong Wang, Ke Ye +4 more
202010 citations
Semantic Scholar
Genomic and transcriptomic insights into the precision treatment of pulmonary enteric adenocarcinoma.
Yuan Liu, Tao Lu, M. Yuan, Rong-Rong Chen +4 more
2023Lung Cancer9 citations
Semantic Scholar
Genomic Alterations Identification and Resistance Mechanisms Exploration of NSCLC With Central Nervous System Metastases Using Liquid Biopsy of Cerebrospinal Fluid: A Real-World Study
Fangfang Shen, N. Liang, Zai-Wen Fan, Min Zhao +11 more
2022Frontiers in Oncology9 citations Open access
Semantic Scholar
Identification of novel ALK fusions using DNA / RNA sequencing in immunohistochemistry / RT-PCR discordant NSCLC patients.
Bei Wang, Rong-Rong Chen, Chang-Xi Wang, Jia Guo +4 more
2021Human Pathology9 citations
Semantic Scholar
Assessment of durable chemoimmunotherapy response via circulating tumor DNA in advanced esophageal squamous cell carcinoma
Dongyang Yang, Fei Xu, Ying Li, X. Lai +5 more
2022Thoracic Cancer8 citations Open access
Semantic Scholar
The influence of STK11 mutation on acquired resistance to immunotherapy in advanced non-small cell lung cancer with Lynch syndrome: a case report and literature review.
Yaling Long, Yuan Tang, C. Cai, Min Yu +3 more
2021Annals of Palliative Medicine8 citations Open access
Semantic Scholar
Clinicopathological and molecular characteristics of patients with hypermutant lung cancer: A retrospective cohort study
Hong-Bin Zhang, Yuan Wang, Q. Ji, Hong-Mei Cai +10 more
2021Oncology Letters8 citations Open access
Semantic Scholar
Molecular Characteristics of the Uncommon EGFR Exon 21 T854A Mutation and Response to Osimertinib in Patients With Non-Small Cell Lung Cancer.
Lihong Zhang, Xia Yang, Zong-juan Ming, Jie Shi +14 more
2021Clinical Lung Cancer7 citations Open access
Semantic Scholar
BRAF V600E mutation as a novel mechanism of acquired resistance to ALK inhibition in ALK-rearranged lung adenocarcinoma
Ai-Xia Sui, Hui-Ling Song, Yi-Tong Li, Li-Tao Guo +3 more
2021Medicine7 citations Open access
Semantic Scholar
Oncogenic mutations within the β3‐αC loop of EGFR/ERBB2/BRAF/MAP2K1 predict response to therapies
Biao Zhang, Yongsheng Chen, P. Dai, Haoda Yu +11 more
2020Molecular Genetics & Genomic Medicine7 citations Open access
Semantic Scholar
Chr2 30297612-ALK, A Novel Intergenic Fusion With Exon18 of ALK, Responds to Crizotinib.
Xiao-Feng Chen, Guohong Zhao, Peilin Zhong, Min Zhang +2 more
2020Clinical Lung Cancer7 citations
Semantic Scholar
EGFR extracellular domain mutation in patients with lung cancer.
R. Guo, D. Gu, Jun Zhao, Lingjun Zhu +5 more
2019Journal of Clinical Oncology7 citations
Semantic Scholar
Genomic Characteristics and the Potential Clinical Implications in Oligometastatic Non–Small Cell Lung Cancer
R. Liao, Ke-Qian Chen, Jin-Jin Li, Hengqiu He +8 more
2023Cancer research and treatment : official journal of Korean Cancer Association6 citations Open access
Semantic Scholar
Comprehensive analysis of MET mutations in NSCLC patients in a real-world setting
X. Ai, Yong-Feng Yu, Jun Zhao, Wang Sheng +6 more
2022Therapeutic Advances in Medical Oncology6 citations Open access
Semantic Scholar
Combined treatment with anlotinib and chemotherapy for advanced esophageal squamous cell carcinoma improved patient survival: a case report.
Dongyang Yang, Fei Xu, X. Lai, Ying Li +4 more
2020American journal of translational research6 citations
Semantic Scholar
Structure-based classification of EGFR mutations in operable pre-invasive and invasive non-small cell lung cancer: a cross-sectional study
Tao Wang, Jun Cao, Qilong Song, L. xilinx Wang +2 more
2022Journal of Thoracic Disease5 citations Open access
Semantic Scholar
ctDNA facilitated the diagnosis of a patient with synchronous urothelial carcinoma and non-small cell lung cancer: case report
Cheng-Yuan Qian, N. Dai, Mingfang Xu, Hao Luo +4 more
2020Annals of Translational Medicine5 citations Open access
Semantic Scholar
RET fusion in first/third-generation EGFR-TKIs resistance in advanced non-small cell lung cancer.
Yu Yao, Min Zhang, Xiuju Liu, Jun Zhao +6 more
2019Journal of Clinical Oncology5 citations
Semantic Scholar
Coexistence of a novel SV2B-ALK, EML4-ALK double-fusion in a lung poorly differentiated adenocarcinoma patient and response to alectinib: a case report and literature review
Huang Chen, Meng-Lan Zhang, Liyan Bai, Yun Niu +10 more
2024Frontiers in Oncology4 citations Open access
Semantic Scholar
Genomic characterisation of de novo EGFR copy number gain and its impact on the efficacy of first-line EGFR-tyrosine kinase inhibitors for EGFR mutated non-small cell lung cancer.
Yiquan Xu, Jingjing Yan, Cheng-Zhi Zhou, Lin Wu +18 more
2023European Journal of Cancer4 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

M. Yuan×12
Invite
M. Yuan — researcher profile on SciRah
X. Xia×9
Invite
X. Xia — researcher profile on SciRah
Jun Zhao×8
Invite
Jun Zhao — researcher profile on SciRah
D. Gu×7
Invite
D. Gu — researcher profile on SciRah

×6

Invite

X. Yi — researcher profile on SciRah

Cheng-Zhi Zhou×6

Invite

Cheng-Zhi Zhou — researcher profile on SciRah

Invite

Yu Xiong — researcher profile on SciRah

Invite

X. Ai — researcher profile on SciRah

Invite

Min Zhang — researcher profile on SciRah

Invite

R. Guo — researcher profile on SciRah

Invite

L. Chang — researcher profile on SciRah

Invite

Shun Lu — researcher profile on SciRah